Author:
Hohlfeld Thomas,Schrör Karsten
Reference172 articles.
1. AIMS trial study group (1988) Effect of intravenous APSAC on mortality after myocardial infarction: preliminary report of a placebo-controlled clinical trial. Lancet 1:545–549
2. Armstrong PW, Langevin LM, Watts DG (1988) Randomized trial of prostacyclin infusion in acute myocardial infarction. Am J Cardiol 61:455–457
3. Azuma H, Ishikawa M, Sekizaki S (1986) Endothelium-dependent inhibition of platelet aggregation. Br J Pharmacol 88:411–415
4. Bang U, Wilhelm OG, Clayman MD (1989) Thrombolytic therapy in acute myocardial infarction. Ann Rev Pharmacol Tox 29:323–341
5. Bassand J-P, Machecourt J, Cassagne J, Anguenot T, Lusson R, Borel E, Peycelon P, Wolf E, Ducellier D (1989) Multicenter trial of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) in acute myocardial infarction: Effects on infarct size and left ventricular function. J Am Coll Cardiol 13:988–997